NIP 121

Drug Profile

NIP 121

Latest Information Update: 31 Jan 2008

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator Nissan Chemical Industries
  • Class Antiasthmatics; Antihypertensives; Oxadiazoles; Piperidines; Small molecules; Vasodilators
  • Mechanism of Action Potassium channel agonists
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Asthma; Hypertension; Myocardial ischaemia

Most Recent Events

  • 21 Feb 2000 Discontinued-Preclinical for Myocardial ischaemia in Japan (Unknown route)
  • 21 Feb 2000 Suspended-Preclinical for Asthma in Japan (Unknown route)
  • 21 Feb 2000 Suspended-Preclinical for Hypertension in Japan (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top